Literature DB >> 16879061

Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium.

Andries J Bakker1, E Christiaan Boerma, Halbe Keidel, Peter Kingma, Peter H J van der Voort.   

Abstract

BACKGROUND: The objective of this study was to elucidate the most practical and effective laboratory measurement for monitoring citrate in critically ill patients undergoing citrate-anticoagulated continuous venovenous haemofiltration (CVVH).
METHODS: This observational study was performed at the mixed medical and surgical intensive care unit of a regional teaching hospital. The study population comprised ten consecutive critically ill patients with acute renal failure and indication for haemofiltration with the use of regional anticoagulation with citrate. Serum samples for the measurement of citrate and total and ionised calcium were taken from the pre- and post-filter compartments and from the arterial circulation of patients during citrate-anticoagulated CVVH.
RESULTS: Receiver operating characteristic (ROC) curve analysis showed that for detecting citrate overdose (defined as a citrate concentration >1.0 mmol/L) the best cut-off limits for total/ionised calcium and ionised calcium were 2.1 and 0.8 mmol/L, respectively. Sensitivity and specificity for the cut-off limit of 2.1 for total/ionised calcium were 89% and 100%, and 84% and 100%, respectively, for the cut-off limit of 0.8 mmol/L for ionised calcium.
CONCLUSIONS: In patients without liver insufficiency, total/ionised calcium performed slightly better than ionised calcium in detecting elevated citrate concentrations. However, because of the simplicity of its measurement, ionised calcium is preferred. Measurement of citrate is not necessary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879061     DOI: 10.1515/CCLM.2006.164

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  19 in total

Review 1.  Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.

Authors:  Enrico Fiaccadori; Valentina Pistolesi; Filippo Mariano; Elena Mancini; Giorgio Canepari; Paola Inguaggiato; Marco Pozzato; Santo Morabito
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

2.  Simplified regional citrate anticoagulation using a calcium-containing replacement solution for continuous venovenous hemofiltration.

Authors:  Ling Zhang; Yujie Liao; Jin Xiang; Wei Qin; Xiaodong Wu; Yi Tang; Yingying Yang; Zhiwen Chen; Ping Fu
Journal:  J Artif Organs       Date:  2012-12-28       Impact factor: 1.731

3.  Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium.

Authors:  Martin Kreuzer; Thurid Ahlenstiel; Nele Kanzelmeyer; Jochen H H Ehrich; Lars Pape
Journal:  Pediatr Nephrol       Date:  2010-03-11       Impact factor: 3.714

Review 4.  Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Enrico Fiaccadori
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

5.  Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes.

Authors:  Paola Milla; Maria Luisa Viterbo; Sabino Mosca; Silvia Arpicco
Journal:  Eur J Hosp Pharm       Date:  2017-01-13

Review 6.  Renal replacement therapy: a practical update.

Authors:  George Alvarez; Carla Chrusch; Terry Hulme; Juan G Posadas-Calleja
Journal:  Can J Anaesth       Date:  2019-02-06       Impact factor: 5.063

Review 7.  Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?

Authors:  Heleen M Oudemans-van Straaten; John A Kellum; Rinaldo Bellomo
Journal:  Crit Care       Date:  2011-01-24       Impact factor: 9.097

8.  Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.

Authors:  Heleen M Oudemans-van Straaten; Marlies Ostermann
Journal:  Crit Care       Date:  2012-12-07       Impact factor: 9.097

Review 9.  Clinical review: Patency of the circuit in continuous renal replacement therapy.

Authors:  Michael Joannidis; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

10.  Post-dilution on line haemodiafiltration with citrate dialysate: first clinical experience in chronic dialysis patients.

Authors:  Vincenzo Panichi; Enrico Fiaccadori; Alberto Rosati; Roberto Fanelli; Giada Bernabini; Alessia Scatena; Francesco Pizzarelli
Journal:  ScientificWorldJournal       Date:  2013-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.